Quick Takeaways
- Paradigm Biocapital Advisors LP filed SCHEDULE 13G for Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS).
- Disclosed ownership: 5.3%.
- Date of event: 07 Jan 2026.
Paradigm Biocapital Advisors LP - 07 Jan 2026 SCHEDULE 13G Report for Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS)
- Filing Manager
- Paradigm Biocapital Advisors LP
- Reporting Manager
- Paradigm BioCapital Advisors LP
- Symbol
- ERAS
- Shares outstanding
- 286,020,660 shares
- Disclosed Ownership
- 15,159,095 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Jan 2026, 16:30:13 UTC
- Date of event
- 07 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Paradigm Biocapital Advisors LP disclosed 5.3% ownership in Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS) on 07 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Jan 2026, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | 5.3% | 15,159,095 | 15,159,095 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Paradigm BioCapital Advisors GP LLC | 5.3% | 15,159,095 | 15,159,095 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Senai Asefaw, M.D. | 5.3% | 15,159,095 | 15,159,095 | 0 | /s/ Senai Asefaw, M.D. | N/A | |
| Paradigm BioCapital International Fund Ltd. | 4.7% | 13,377,027 | 13,377,027 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory |